SK Biopharmaceuticals will divest a 12% stake in Arvelle, which is looking to commercialise an epilepsy drug treatment, through the acquisition.

Bristol Myers Squibb participated in a series B round for the oncology drug developer that pushed its overall funding to $168m.

The oncolytic virus therapy-based cancer drug developer raised $77m in a GV-backed series A round as it prepares to file an IND application next year.

Amazon has agreed to acquire Walt Disney and Bertelsmann-backed podcast creator and publisher Wondery for about $300m.

Ionis Pharmaceuticals and Johnson & Johnson Innovation – JJDC were among the investors in a round that will fund development of Aro's centyrin-RNA conjugate medicines.

The corporate will get a majority stake in end-to-end construction services provider Katerra, helping it avoid bankruptcy protection.

The Alphabet, GSK, WuXi AppTec, Johnson & Johnson, Roche and Illumina-backed genetic testing service has now raised over $870m altogether.

Hanwha Systems has agreed to provide $30m in funding for the satellite technology provider, whose existing investors include Liberty Global and Intelsat.

The Green Bay Packers, Milwaukee Bucks and Milwaukee Brewers joined Microsoft in backing an impact investment arm of venture capital fund TitletownTech.

Restructure at BP follows Meghan Sharp's return as global head of ventures.